Iran J Basic Med Sci. 2019 Sep;22(9):1065-1072. doi: 10.22038/ijbms.2019.36127.8605.
The effects of supraphysiological levels of testosterone on neural networks upstream of gonadotropin-releasing hormone neurons.
Iranian journal of basic medical sciences
Mohammad Saied Salehi, Homayoun Khazali, Fariba Mahmoudi, Mahyar Janahmadi
Affiliations
Affiliations
- Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Animal Physiology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
- Faculty of Basic Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
- Neuroscience Research Center and Department of Physiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
PMID: 31807251
PMCID: PMC6880527 DOI: 10.22038/ijbms.2019.36127.8605
Abstract
OBJECTIVES: Several pathological conditions are associated with hyper-production of testosterone; however, its impacts are not well understood. Hence, we evaluated the effects of supraphysiological levels of testosterone on gonadotropin-releasing hormone (GnRH) system in the hypothalamus of male rats. Also, we assessed the expression of two excitatory (kisspeptin and neurokinin-B) and two inhibitory (dynorphin and RFamide-related-peptide) neuropeptides upstream of GnRH neurons as possible routes to relay androgen information.
MATERIALS AND METHODS: Gonadectomized (GDX) male rats received single injection of 100, 250 or 500 mg/kg testosterone undecanoate and three weeks later, posterior (PH) and anterior (AH) hypothalamus was dissected for evaluation of target genes using quantitative RT-PCR.
RESULTS: We found that GnRH mRNA in the PH was high in GDX rats and 500 mg/kg testosterone reduced GnRH level expression. Finding revealed extremely high level of Kiss1 mRNA in the PH of GDX rats. However, in GDX rats treated with different levels of testosterone, Kiss1 expression was not significantly different than control. We also found that testosterone replacement increased the Kiss1 mRNA level in the AH. Moreover, neurokinin-B mRNA level in PH of GDX rats was similar to control. However, excess testosterone levels were effective in significantly inducing the down-regulation of neurokinin-B expression. The basal level of dynorphin mRNA was increased following testosterone treatments in the AH, where we found no significant difference in the level of RFamide-related-peptide mRNA between the experimental groups.
CONCLUSION: Excess levels of testosterone could act differently from its physiological concentration to regulate hypothalamic androgen sensitive neurons to control GnRH cell.
Keywords: GnRH; Kisspeptin; Neurokinin B; RFRP; Testosterone
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
- Brain Res. 1988 Jun 7;451(1-2):255-60 - PubMed
- Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E202-10 - PubMed
- J Neuroendocrinol. 2017 Feb;29(2): - PubMed
- Endocrinology. 2012 Apr;153(4):1827-40 - PubMed
- Endocrinology. 2005 Jul;146(7):2976-84 - PubMed
- Endocrinology. 1990 Aug;127(2):523-32 - PubMed
- J Neuroendocrinol. 2008 Dec;20(12):1376-81 - PubMed
- Neuroendocrinology. 2011;94(4):323-32 - PubMed
- Neuroendocrinology. 2014;99(1):7-17 - PubMed
- Endocrinology. 2012 Oct;153(10):4818-29 - PubMed
- Methods. 2001 Dec;25(4):402-8 - PubMed
- Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2410-5 - PubMed
- Endocrinology. 1990 Feb;126(2):1080-6 - PubMed
- J Neurosci. 2009 Sep 23;29(38):11859-66 - PubMed
- Biol Reprod. 2001 Mar;64(3):735-42 - PubMed
- J Neurosci. 2009 Jul 22;29(29):9390-5 - PubMed
- Endocrinology. 2005 Apr;146(4):1835-42 - PubMed
- Brain Res. 1993 Oct 8;624(1-2):309-11 - PubMed
- Nature. 1981 Dec 24;294(5843):757-9 - PubMed
- Endocrinology. 2012 Nov;153(11):5428-39 - PubMed
- Neuropeptides. 2006 Apr;40(2):115-23 - PubMed
- J Neurosci. 2012 Feb 15;32(7):2388-97 - PubMed
- Life Sci. 1982 May 31;30(22):1915-9 - PubMed
- Exp Clin Endocrinol Diabetes. 2003 Jun;111(4):203-8 - PubMed
- J Comp Neurol. 2005 Aug 29;489(3):372-86 - PubMed
- Exp Brain Res. 1987;67(1):113-8 - PubMed
- Neuroendocrinology. 2004;80(4):264-72 - PubMed
- J Neuroendocrinol. 2010 Jul;22(7):692-700 - PubMed
- J Neurosci. 2010 Feb 24;30(8):3124-32 - PubMed
- Endocrinology. 2008 Mar;149(3):902-12 - PubMed
- Br J Sports Med. 2010 Jan;44(1):26-31 - PubMed
- Peptides. 2009 Jan;30(1):26-33 - PubMed
- J Clin Endocrinol Metab. 2010 Apr;95(4):1533-43 - PubMed
- Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):200-4 - PubMed
- Iran J Basic Med Sci. 2018 Dec;21(12):1210-1220 - PubMed
- Endocrinology. 2004 Jun;145(6):2959-67 - PubMed
- Endocrinology. 1991 Jan;128(1):459-66 - PubMed
- Endocrinology. 2011 Apr;152(4):1684-90 - PubMed
- J Endocrinol. 1986 May;109(2):291-6 - PubMed
- Neurosci Lett. 1994 Dec 5;182(2):193-6 - PubMed
- Int J Fertil Steril. 2015 Oct-Dec;9(3):268-76 - PubMed
- J Neuroendocrinol. 2007 Jun;19(6):432-8 - PubMed
Publication Types